IVTA appears to be increasingly popular to treat those with visual loss from macular edema; thus the prevalence of its associated corticosteroid-induced ocular hypertension will continue to rise.

• 玻璃体内注射曲安奈德来治疗黄斑水肿所致的视力下降看起来越来越流行，因此与之相关的类固醇诱导性高眼压的发病率将持续升高。